Mazkur tadqiqot ishida oliy ta’lim muassasalarida to‘lov-kontrakt narxlarining shakllanish jarayoni hamda uning ta’lim xizmatlari tannarxi bilan bog‘liqligi o‘rganilgan. Tadqiqot davomida oliy ta’lim xizmatining iqtisodiy mohiyati, kontrakt tizimining ahamiyati hamda ta’lim xizmatlari tannarxini shakllantiruvchi asosiy omillar tahlil qilingan. Shuningdek, kontrakt narxlarini belgilash jarayoniga ta’sir etuvchi iqtisodiy omillar va ularning o‘zaro bog‘liqligi ko‘rib chiqilgan. Tadqiqot natijasida oliy ta’lim muassasalarida kontrakt narxlarini iqtisodiy jihatdan asosli shakllantirish hamda ta’lim xizmatlari tannarxini hisoblashni takomillashtirish bo‘yicha taklif va tavsiyalar ishlab chiqilgan.

Ushbu maqolada Sharq mutafakkirlarining islom dini ta’limoti asosida inson kamoloti borasidagi g‘oyalari tadqiq etilgan. Xususan, islomiy sifatlar va axloqiy mezonlarning shaxs ma’naviy yuksalishidagi roli qiyosiy-falsafiy nuqtai nazardan tahlil qilingan.

Ushbu maqolada Shukur Xolmirzayev ijodining bugungi kundagi o‘rni va ahamiyati badiiy-tahliliy yondashuv asosida yoritiladi. Adibning asarlari go‘yo hayotning o‘zidan o‘yib olingan lavhalardek o‘quvchi qalbiga kirib boradi, inson ruhiyatining eng nozik qatlamlarini ochib beradi. Maqolada yozuvchining hikoya va qissalarida aks etgan insoniylik, vijdon, tabiat va jamiyat o‘rtasidagi murakkab munosabatlar chuqur tahlil qilinadi. Shuningdek, muallif ijodidagi obrazlar — hayot shamollarida toblangan, dard va umid oralig‘ida yashayotgan insonlar timsoli sifatida talqin etiladi. Ularning ichki kechinmalari goh sokin daryo misol, goh to‘lqinlangan dengizdek tasvirlanib, o‘quvchini befarq qoldirmaydi. Maqolada Shukur Xolmirzayev asarlarining bugungi globallashuv davrida milliy o‘zlikni asrash, ma’naviy qadriyatlarni mustahkamlashdagi o‘rni alohida ta’kidlanadi. Mazkur tadqiqot yozuvchi ijodining zamonlar osha so‘nmas ma’naviy chiroq ekanini, uning asarlari esa inson qalbining eng yashirin torlarini chertuvchi betakror badiiy olam ekanini ochib beradi.

В статье представлен сравнительный анализ институциональных моделей венчурного финансирования в Республике Узбекистан и в ряде зарубежных стран, включая США и Израиль. Рассматриваются особенности становления венчурных рынков, роль государства, а также степень участия частного капитала в инвестиционных процессах. Отдельное внимание уделено текущим реформам в Узбекистане, связанным с внедрением модели «фонд фондов» и расширением инструментов государственной поддержки инновационных проектов. В результате проведённого анализа выявлены ключевые ограничения национальной модели, в числе которых — низкая активность частного сектора и дефицит проектов на стадии роста (Series A и выше), при том что большинство инициатив находятся на ранней (early stage) стадии развития. На этой основе предложены направления формирования более устойчивой системы венчурного финансирования.

Childhood Hodgkin lymphoma is one of the most curable pediatric malignancies, with long-term overall survival now approaching 90%–98% in modern cooperative-group series. Because cure is achieved in the great majority of patients, the central question in contemporary management is no longer whether children can be cured, but how they can be cured with the lowest possible burden of late toxicity. Combination therapy has therefore evolved from broad-field radiotherapy plus intensive chemotherapy toward risk-adapted, response-based multiagent regimens in which chemotherapy intensity, use of radiotherapy, and more recently incorporation of targeted agents are tailored according to stage, tumor bulk, B symptoms, and early treatment response. This review analyzes the results of combination treatment in childhood Hodgkin lymphoma with emphasis on major pediatric trials, including P9425, AHOD0031, GPOH-HD-2002, EuroNet-PHL-C1, AHOD0831, and AHOD1331. A narrative review methodology was used to identify landmark studies, late-effect cohorts, and contemporary reviews relevant to combined-modality therapy in children and adolescents. The published evidence shows that multiagent chemotherapy remains the therapeutic backbone, while radiotherapy can be safely omitted in selected patients with favorable early response. At the same time, targeted augmentation of chemotherapy with brentuximab vedotin has improved outcomes in high-risk disease without a clear increase in acute toxicity. The major challenge remains balancing event-free survival with long-term risks such as infertility, cardiotoxicity, pulmonary damage, and second malignant neoplasms. Current data support a modern paradigm of biologically and clinically individualized combination therapy, in which disease control and survivorship are considered equally important endpoints [1-17].